[{"Assets_0_Q1_USD":"1179044000.0","CIK":"1737287","CommonStockSharesConverted_0_Q1_shares":"141470075.0","CommonStockSharesOutstanding_0_Q1_shares":"141470075.0","Country":"United States","EarningsPerShareBasic_1_Q1_USD":"-0.25","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","Market Cap":"1134878416.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":"-49328000.0","NetIncomeLoss_1_Q1_USD":"-33015000.0","OfficialName":"Allogene Therapeutics Inc. Common Stock","ProfitLoss_1_Q1_USD":"-33015000.0","RevenuesConverted_1_Q1_USD":"38345000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q1_USD":"1069779000.0","Ticker":"ALLO","filed":"20210505","footnote":null,"form":"10-Q","fp":"Q1","fy":"2021.0","name":"ALLOGENE THERAPEUTICS, INC.","period":"20210331","qtrs":"1","uom":"USD"}]